French pharmaceutical giant Sanofi announced on Thursday it would cut the US price of its most prescribed insulin by 78 percent, falling in line with two
Digital Journal's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
Names this update
Sanofi, joining other drug makers, slashes US insulin price
Headline from Digital Journal ·
Newest
Sanofi becomes latest drugmaker to announce insulin price cuts, capping cost at $35 for the privately insured
The French drugmaker is the last major insulin manufacturer to try to head off government efforts to cap monthly costs by announcing its own steep price cuts.
French pharmaceutical giant Sanofi announced on Thursday it would cut the US price of its most prescribed insulin by 78 percent, falling in line with two
By Tami Luhby, CNN Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78% and establishing a $35 monthly cap for those with private insurance, the company announced Thursday. The change is effective January 1.
(CNN) — Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78% and establishing a $35 monthly cap for those with private insurance, the company announced Thursday. The change is effective Jan. 1, 2024.
Sanofi is planning to cut the U.S. price of its most-prescribed insulin by 78% and cap monthly out-of-pocket costs at $35 for people who have private insurance.
French pharmaceutical giant Sanofi announced on Thursday it would cut the US price of its most prescribed insulin by 78 percent, falling in line with two other major drug makers.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Sanofi, joining other drug makers, slashes US insulin price | Since Then
